The IMAGE trial

Melanoma surveillance photography is a comprehensive surveillance method.

To date, there is insufficient evidence that Melanoma Surveillance Photography improves outcomes. Currently, melanoma surveillance photography is not used routinely during skin examinations as part of ‘standard care’.

Melanoma Surveillance Photography is not reimbursed by Medicare and is often costly.

This project will test whether people who are monitored with Melanoma Surveillance Photography, have fewer benign lesions removed or sampled, compared to those who do not have Melanoma Surveillance Photography.

The IMAGE clinical trial will help provide the information needed by the Medical Services Advisory Committee (the committee advising the Australian Government on the public funding of new medical services), to decide if Melanoma Surveillance Photography should be covered by Medicare.